777 related articles for article (PubMed ID: 12917944)
1. G-CSF and GM-CSF for treating or preventing neonatal infections.
Carr R; Modi N; Doré C
Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
[TBL] [Abstract][Full Text] [Related]
2. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia.
Mohan P; Brocklehurst P
Cochrane Database Syst Rev; 2003; (4):CD003956. PubMed ID: 14584000
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
[TBL] [Abstract][Full Text] [Related]
6. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
Bohlius J; Reiser M; Schwarzer G; Engert A
Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2001; (2):CD000361. PubMed ID: 11405962
[TBL] [Abstract][Full Text] [Related]
8. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
Bohlius J; Reiser M; Schwarzer G; Engert A
Cochrane Database Syst Rev; 2004; (1):CD003189. PubMed ID: 14974009
[TBL] [Abstract][Full Text] [Related]
9. Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma.
Bohlius J; Reiser M; Schwarzer G; Engert A
Cochrane Database Syst Rev; 2002; (4):CD003189. PubMed ID: 12519588
[TBL] [Abstract][Full Text] [Related]
10. Colony-stimulating factors for chemotherapy-induced febrile neutropenia.
Mhaskar R; Clark OA; Lyman G; Engel Ayer Botrel T; Morganti Paladini L; Djulbegovic B
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003039. PubMed ID: 25356786
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline for neonatal sepsis.
Haque K; Mohan P
Cochrane Database Syst Rev; 2003; (4):CD004205. PubMed ID: 14584009
[TBL] [Abstract][Full Text] [Related]
12. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
Bohlius J; Herbst C; Reiser M; Schwarzer G; Engert A
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD003189. PubMed ID: 18843642
[TBL] [Abstract][Full Text] [Related]
13. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
14. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.
Bohlius J; Reiser M; Schwarzer G; Engert A
Br J Haematol; 2003 Aug; 122(3):413-23. PubMed ID: 12877668
[TBL] [Abstract][Full Text] [Related]
15. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2004; (1):CD001239. PubMed ID: 14973965
[TBL] [Abstract][Full Text] [Related]
17. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
Carr R; Brocklehurst P; Doré CJ; Modi N
Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction.
Massey E; Paulus U; Doree C; Stanworth S
Cochrane Database Syst Rev; 2009 Jan; (1):CD005341. PubMed ID: 19160254
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction.
Estcourt LJ; Stanworth S; Doree C; Blanco P; Hopewell S; Trivella M; Massey E
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD005341. PubMed ID: 26118415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
